BECTON DICKINSON & CO (BDX)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$180.77
-0.72%
Investingg Score
47.7 / 100
Sell
Business overview
- Operating margin stands at 11.8%.
- Free cash flow margin is recorded at 12.2%.
These margins reflect moderate operational efficiency in generating core earnings and cash flow from operations.
Financial health
- Balance sheet pillar score is 32 out of 100.
- Financial quality pillar score is 30 out of 100.
These scores indicate constrained financial health and quality profiles based on the evaluated metrics.
- Gross Margin
- Data unavailable
- Operating Margin
- 11.8%
- Current Ratio
- 1.1x
- Debt / Equity
- 0.69
- Free Cash Flow (TTM)
- $2.7B
- Interest Coverage
- 4x
Valuation
- EV to EBITDA ratio is 3.77.
- Valuation pillar score is 58.
The low enterprise multiple suggests the stock may be priced attractively relative to earnings before interest, taxes, depreciation, and amortization, though other valuation figures are unavailable.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- Price / Sales
- 0.0x
- EV / EBITDA
- 3.8x
- FCF Yield
- Data unavailable
Key risks
- Year-over-year earnings per share growth is negative at -0.7%.
- RSI stands at 72.61, signaling potential overbought technical risk.
- Financial quality score of 30 suggests underlying business quality challenges.
Market cap $0 · data as of 2026-08-18
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze BDX with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.